title: Characteristics of immune rejection after allogeneic cultivated limbal epithelial transplantation.
abstract: OBJECTIVE
  To investigate the characteristics and prognosis of immune rejection after allogeneic cultivated limbal epithelial transplantation (CLET).
  
  
  METHODS
  Retrospective, noncomparative case series.
  
  
  METHODS
  Forty-two eyes of 41 patients undergoing allogeneic CLET for total limbal stem cell deficiency who completed a follow-up of at least 12 months.
  
  
  METHODS
  Allogeneic cultivated limbal epithelial cells using human amniotic membrane as a carrier were transplanted into the recipient eye. Immune rejection occurred in 10 eyes; the medical records of these patients were reviewed.
  
  
  METHODS
  Best-corrected visual acuity, corneal opacification and neovascularization, immunofluorescence staining of CD4 and CD8 T cells, and distribution of Langerhans cells (LCs) in the corneal epithelium.
  
  
  RESULTS
  The corneal epithelium became edematous with epithelial rejection lines and peripheral epithelial defects in 6 eyes. Circumlimbal vessels were hyperemic and extended up to the corneal stroma, thus resulting in aggravation of corneal neovascularization in 8 eyes. Corneal stromal opacification was observed in 9 eyes. CD4(+) or CD8(+) T cells were detected in 5 of 6 eyes from which impression cytology specimens were obtained. In vivo confocal microscopy examination revealed an accumulation of LCs in the central and peripheral corneal epithelium. All patients responded to antirejection therapy. One eye developed a second episode.
  
  
  CONCLUSIONS
  The diagnosis of immune rejection after allogeneic CLET mainly depends on typical clinical manifestations. Delayed recognition can result in worsening corneal opacification and neovascularization. Reasonable use of topical immunosuppressives and a close follow-up within 6 months after allogeneic CLET are critical to improve the prognosis.
  
  
  BACKGROUND
  The author(s) have no proprietary or commercial interest in any materials discussed in this article.
authors: Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, China.
authors: Xiaolin
authors: X
authors: Qi
authors: Lixin
authors: L
authors: Xie
authors: Jun
authors: J
authors: Cheng
authors: Hualei
authors: H
authors: Zhai
authors: Qingjun
authors: Q
authors: Zhou
mesh_terms: D000293:Adolescent; D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D002648:Child; D003316:Corneal Diseases / Q000276:immunology / Q000601:surgery*; D016039:Corneal Transplantation / Q000379:methods*; D019573:Epithelium, Corneal / Q000276:immunology / Q000473:pathology / Q000637:transplantation*; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007801:Langerhans Cells / Q000473:pathology; D016850:Limbus Corneae / Q000166:cytology*; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic; D012189:Retrospective Studies; D014792:Visual Acuity; D055815:Young Adult